783 results on '"Neckers, Len"'
Search Results
52. Chapter Four: Hsp90 in Cancer: Transcriptional Roles in the Nucleus
53. Heat Shock Protein 90 and the Proteasome
54. Contributors
55. UOK 262 cell line, fumarate hydratase deficient ( FH−/ FH−) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer
56. Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma
57. MP39-02 OVEREXPRESSION OF MPS1 IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC) CONFERS TUMOR SELECTIVITY ON HEAT SHOCK PROTEIN-90 (HSP90) INHIBITORS
58. KIT regulates tyrosine phosphorylation and nuclear localization of β-catenin in mast cell leukemia
59. Chaperoning parasitism: the importance of molecular chaperones in pathogen virulence
60. THE HSP90 INHIBITOR GANETESPIB SYNERGIZES WITH THE MET KINASE INHIBITOR CRIZOTINIB IN BOTH CRIZOTINIB-SENSITIVE AND CRIZOTINIB-RESISTANT MET-DRIVEN RENAL TUMOR MODELS: MP35-12
61. The complex dance of the molecular chaperone Hsp90
62. Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90
63. HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts
64. Additional file 2 of The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis
65. Additional file 12 of The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis
66. Additional file 6 of The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis
67. Additional file 5 of The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis
68. Tumour necrosis factor receptor 1 mediates endoplasmic reticulum stress‐induced activation of the MAP kinase JNK
69. The Cancer Super-chaperone Hsp90: Drug Targeting and Post-translational Regulation
70. Metabolic and Pharmacological Properties of Rutin, a Dietary Quercetin Glycoside, for Treatment of Inflammatory Bowel Disease
71. CHIP activates HSF1 and confers protection against apoptosis and cellular stress
72. New Insights into von Hippel-Lindau Function Highlighted by Investigation of the Trichloroethylene-Induced p.P81S Hotspot Mutation
73. Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity
74. Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy
75. Detecting HSP90 Phosphorylation
76. Selective Inhibition of HER2-Positive Breast Cancer Cells by the HIV Protease Inhibitor Nelfinavir
77. Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells
78. Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
79. Heat Shock Protein 90 and the Proteasome
80. List of Contributing Authors
81. Hereditary kidney cancer: Unique Opportunity for Disease-based Therapy
82. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
83. Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo
84. Depletion of p185erbB2, Raf-1 and mutant p53 proteins by geldanamycin derivatives correlates with antiproliferative activity
85. Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides
86. Azaspirene, a fungal product, inhibits angiogenesis by blocking Raf-1 activation
87. The Exception that Reinforces the Rule: Crosspriming by Cytosolic Peptides that Escape Degradation
88. Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesion kinase to beta-l-integrin
89. Intratumor Injection of the Hsp90 Inhibitor 17AAG Decreases Tumor Growth and Induces Apoptosis in a Prostate Cancer Xenograft Model
90. Extracellular heat shock protein 90: A role for a molecular chaperone in cell motility and cancer metastasis
91. Drugging the Cancer Chaperone HSP90: Combinatorial Therapeutic Exploitation of Oncogene Addiction and Tumor Stress
92. Mechanisms of Disease: hereditary leiomyomatosis and renal cell cancer-a distinct form of hereditary kidney cancer
93. Rapid deubiquitination of nucleosomal histones in human tumor cells caused by proteasome inhibitors and stress response inducers: Effects on replication, transcription, translation, and the cellular stress response
94. Phase I and Pharmacologic Study of 17-(Allylamino)-17-Demethoxygeldanamycin in Adult Patients With Solid Tumors
95. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib
96. 17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells
97. Cancer: The rules of attraction
98. Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228
99. Antisense technology: biological utility and practical considerations
100. Heat shock protein 90 as a molecular target for cancer therapeutics
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.